Skip to contentI
INSMED Inc
I
INSMINSMED Inc Q4 2019 · 10-K
Revenue$45.71M$45.71M+364.7% vs Q4 2018 Net Income-$52.99M-$52.99MN/M vs Q4 2018 EPS Diluted-$0.59-$0.59N/M vs Q4 2018 Gross Profit$37,002,000+399.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
Operating Cash Flowderived-$44,404,000N/M Free Cash Flowderived-$57,442,000N/M Margins · derivedGross margin81.0%+5.6 pt vs Q4 2018
Operating margin-103.0%+788.9 pt vs Q4 2018
Net margin-115.9%+815.2 pt vs Q4 2018
ended Dec 31, 2019 · filed Feb 25, 2020 · 56 d after period end